By CARLA K. JOHNSON – 8/24/2022 The compound in psychedelic mushrooms helped heavy drinkers cut back or quit entirely in the most rigorous test of psilocybin for alcoholism. More research is needed to see if the effect lasts and whether it works in a larger study. Many who took a dummy drug instead of psilocybin […]
‘Magic mushroom’ psychedelic may help heavy drinkers quit Read More »
A recent article by Calder et al. 2022, highlights in detail how classic psychedelics such as psilocybin, LSD and DMT enhance and sustain neuroplasticity and neurogenesis, the growth of new neural connections in the brain. The article analyzes which parts of the brain are most likely to be affected by neurogenesis and possible clinical ramifications
Ketamine was originally approved by the US Food and Drug Administration (FDA) as an anesthetic, but is increasingly being used to treat mood disorders, such as treatment-resistant depression, anxiety disorders, and post-traumatic stress disorder (PTSD).1,2 Several studies have also found it to be effective for treating suicidal ideation.3,4 “Ketamine can play an important role in the treatment
Ketamine: A Promising Novel Therapy for Anxiety and PTSD Read More »
By Sonya Collins Medically Reviewed by Dan Brennan, MD on May 04, 2022 Jeff Winograd didn’t know an adult life without depression. Since he was 20 years old, he had tried virtually every antidepressant on the market. But he says, “The depression was just a constant.” By the time he was 45 years old, by
Ketamine for Depression: What to Know Read More »
After years of treating patients with Ketamine, one of the most satisfying experiences we have seen has been witnessing the client’s return to functioning. Mental conditions such as depression, PTSD, severe anxiety, etc… can be debilitating and are a huge cause of disability worldwide. In fact, it is well known that mental illness is responsible
In 2021, investors poured a whopping $708 Million into the psychedelic medicine space. As 2022 goes on, even more psychedelic-focused startups are receiving the attention of major investors. So – what’s all the hype about? Ketamine got its start in the 1960s and 1970s as an anesthetic. Now, decades later, ketamine is being heralded as
Investors Look To Ketamine as Revolutionary Treatment for Mental Illness Read More »
At its Tuesday meeting (6 September 2022), the San Francisco Board of Supervisors passed a resolution that initiates the decriminalization of psychedelics like psilocybin, the active component of magic mushrooms. The resolution passed unanimously, and also applies to several other psychedelic compounds. The Board of Supervisors calls for the regulation of certain psychedelic compounds to
San Francisco De-criminalizes Psychedelics Read More »
